Cabozantinib in Thyroid Cancer

Publisher： Bentham Science Publishers

E-ISSN： 2212-3970|10|3|259-269

ISSN： 1574-8928

Source： Recent Patents on Anti-Cancer Drug Discovery, Vol.10, Iss.3, 2015-01, pp. : 259-269

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cabozantinib (XL184) for the treatment of locally advanced or metastatic progressive medullary thyroid cancer

By Viola David   Cappagli Virginia   Elisei Rossella  

Future Oncology, Vol. 9, Iss. 8, 2013-08 ,pp. : 1083-1092

Future Medicine

Access to resources Recommend Favorite

THYROID CANCER

By  

Cancer Investigation, Vol. 25, Iss. 1, 2007-01 ,pp. : 67-68

Informa Healthcare

Access to resources Recommend Favorite

Thyroid cancer following Chernobyl

By Stiller C.A.  

European Journal of Cancer, Vol. 37, Iss. 8, 2001-05 ,pp. : 945-947

Elsevier

Access to resources Recommend Favorite

Molecular pathogenesis of thyroid cancer

By Segev D.L.   Umbricht C.   Zeiger M.A.  

Surgical Oncology, Vol. 12, Iss. 2, 2003-08 ,pp. : 69-90

Elsevier

Access to resources Recommend Favorite

Update on thyroid cancer treatment

By Regalbuto Concetto   Frasca Francesco   Pellegriti Gabriella   Malandrino Pasqualino   Marturano Ilenia   Di Carlo Isidoro   Pezzino Vincenzo  

Future Oncology, Vol. 8, Iss. 10, 2012-10 ,pp. : 1331-1348

Future Medicine

Access to resources Recommend Favorite